vimarsana.com

Latest Breaking News On - Value of digital measures in drug development - Page 1 : vimarsana.com

Biofourmis - the need for clearly defined regulatory approval

Biofourmis and HealthXL Report: Digital Endpoint Support for Pharma Label Claims Expected to Become Common Before 2030

An industry report released today forecasts that digital endpoints will see broader adoption in supporting pharmaceutical and life science label claims in the years ahead but only after industry-wide, pre-competitive collaboration aimed at standardization and proactive sharing of data around clinically validated .

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.